BENG6320

Analyze and contrast the end-to-end manufacturing processes for monoclonal antibodies, antibody-drug conjugates (ADCs), and viral vector vaccines

Evaluate the regulatory approval pathways for different classes of biologics and assess the impact of Quality by Design (QbD) principles on process development

Propose process design improvements to enhance yield, purity, and safety, specifically addressing the challenges of continuous manufacturing in this sector

Communicate with industry partners to receive training from SMEs in this field